Keywords: progenics, drug, shows, anti-hiv, activity, biopharmaceutical, company

Progenics Drug Shows Anti-HIV Activity

Article | 12 June 1995

US biopharmaceutical company Progenics has reported that its candidate AIDS drug PRO 542 "potently and broadly neutralizes" clinical strains of HIV ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in